• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Cosmetics
  • Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

Friday, 28 May 2021 / Published in Cosmetics, News, NMPA Registration in China

Guidelines for the Information Submission of Cosmetics Registration and Filing (Trial Version)

In accordance with the CSAR (Cosmetics Supervision and Administration Regulation), the NMPA (National Medical Products Administration) released the Technical Guidelines for the Submission of Information for Cosmetics Registration and Filing (Trial Version) on April 25, 2021.

Highlights

  • The regulatory draft applies to the registration and filing process of both cosmetics and new ingredients, e.g., user account activation and data submission.
  • Once the Domestic Responsible Agent (DRA) has obtained the digital certificate (Certificate Authority, CA), the submission of the paper version can be replaced by the digital version to the NMPA. The changes before and after the implementation of this trial version is listed below:
    • Before the implementation
      • The digital certificate (Certificate Authority, CA) didn’t exist.
      • The NMPA accepts the original hard copy of the required documents (registrant/filer application form, adverse reaction monitoring overview form, quality management system overview form, etc.) that must be signed and stamped for submission.
    • After the implementation
      • The digital certificate (Certificate Authority, CA) was introduced in the technical guidelines for this trial version.
      • The NMPA accepts the original hard copy or electronic version of the required documents (registrant/filer application form, adverse reaction monitoring overview form, quality management system overview form, etc.) that still must be signed and stamped for submission. However, the DRA needs to obtain the CA to meet the precondition for submitting the electronic version.

By James Xu. Contact Cisema if you would like to learn more.

Tagged under: cosmetics, cosmetics filing, cosmetics registration

What you can read next

China's Medical Device Classification Sodium Hyaluronate
China’s Medical Device Classification of Sodium Hyaluronate Products is Now Open for Comments
Medical Device Electronic Submission System
Regulatory Requirements for Medical Devices in China
SPECTARIS & Cisema Webinar: Regulatory Requirements for Medical Devices in China

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China medical device sampling inspection results

    China medical device sampling inspection results no.4 of 2022

    China medical device sampling inspection result...
  • NMPA cosmetic sampling inspection

    The NMPA Cosmetic Sampling Inspection measures come into force on March 1, 2023

    NMPA Cosmetic Sampling Inspection Measures come...
  • China cosmetics quality safety responsibilities

    China cosmetics quality and safety responsibilities regulations released

    China cosmetics quality and safety responsibili...
  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.